Merck’s Oral Pill for HIV Shows Efficacy in Two Trials By Sam | October 25, 2021 Merck’s investigational once-daily combination pill for HIV has shown positive results in two late-stage trials. Source: Drug Industry Daily Posted in Drug Industry Daily